CN112662815B - Primer-probe combination, kit and method for detecting Takara virus and Tamiami virus - Google Patents
Primer-probe combination, kit and method for detecting Takara virus and Tamiami virus Download PDFInfo
- Publication number
- CN112662815B CN112662815B CN202110096360.6A CN202110096360A CN112662815B CN 112662815 B CN112662815 B CN 112662815B CN 202110096360 A CN202110096360 A CN 202110096360A CN 112662815 B CN112662815 B CN 112662815B
- Authority
- CN
- China
- Prior art keywords
- virus
- primer
- probe
- real
- detection
- Prior art date
- Legal status (The legal status is an assumption and is not a legal conclusion. Google has not performed a legal analysis and makes no representation as to the accuracy of the status listed.)
- Expired - Fee Related
Links
Images
Classifications
-
- Y—GENERAL TAGGING OF NEW TECHNOLOGICAL DEVELOPMENTS; GENERAL TAGGING OF CROSS-SECTIONAL TECHNOLOGIES SPANNING OVER SEVERAL SECTIONS OF THE IPC; TECHNICAL SUBJECTS COVERED BY FORMER USPC CROSS-REFERENCE ART COLLECTIONS [XRACs] AND DIGESTS
- Y02—TECHNOLOGIES OR APPLICATIONS FOR MITIGATION OR ADAPTATION AGAINST CLIMATE CHANGE
- Y02A—TECHNOLOGIES FOR ADAPTATION TO CLIMATE CHANGE
- Y02A50/00—TECHNOLOGIES FOR ADAPTATION TO CLIMATE CHANGE in human health protection, e.g. against extreme weather
- Y02A50/30—Against vector-borne diseases, e.g. mosquito-borne, fly-borne, tick-borne or waterborne diseases whose impact is exacerbated by climate change
Landscapes
- Measuring Or Testing Involving Enzymes Or Micro-Organisms (AREA)
Abstract
本发明涉及病毒检测技术领域,具体涉及用于检测塔卡里伯病毒和太米阿米病毒的引物探针组合、试剂盒及方法。本发明提供用于塔卡里伯病毒和太米阿米病毒的分别或同时实时荧光定量RT‑PCR检测的引物探针组合,其含有两对特异性引物和两条特异性探针,其中,所述特异性引物的序列如SEQ ID NO.1‑4所示,所述特异性探针的序列如SEQ ID NO.5‑6所示。本发明提供的引物探针组合和检测方法具有较高的特异性和灵敏性,可重复性好,检测简便、快速具有实际应用价值。在新的人兽共患病不断出现的形势下,本发明在疾病的早发现、早诊断方面尤显重要意义。The invention relates to the technical field of virus detection, in particular to a combination of primers and probes, a kit and a method for detecting Takaribe virus and Taimiami virus. The present invention provides a combination of primers and probes for respectively or simultaneous real-time fluorescent quantitative RT-PCR detection of Takaribe virus and Taimi virus, which contains two pairs of specific primers and two specific probes, wherein, The sequence of the specific primer is shown in SEQ ID NO.1-4, and the sequence of the specific probe is shown in SEQ ID NO.5-6. The primer-probe combination and detection method provided by the invention have high specificity and sensitivity, good repeatability, simple and rapid detection, and have practical application value. Under the situation that new zoonotic diseases continuously appear, the present invention is particularly important in early detection and diagnosis of diseases.
Description
技术领域technical field
本发明涉及病毒检测技术领域,具体涉及用于检测塔卡里伯病毒和太米阿米病毒的引物探针组合、试剂盒及方法。The invention relates to the technical field of virus detection, in particular to a combination of primers and probes, a kit and a method for detecting Takaribe virus and Taimiami virus.
背景技术Background technique
沙粒病毒由外膜和核衣壳组成,呈圆形,含有脂质(外)胞膜,直径约为50-300nm(平均110-130nm)。外膜表面覆盖有一种蛋白组成的、长度约10nm的纤突,内部可见不同数量的来自宿主细胞的核糖体,在电镜下形如沙粒样,沙粒病毒因此而得名。病毒基因组由双向分节段的单股负义链RNA组成,较大的为L片段,长度约7400个核苷酸,编码RNA依赖的RNA聚合酶L蛋白和具有转录复制调节功能的Z蛋白;较小的为S片段,长度约3400个核苷酸,编码核蛋白NP和糖蛋白GP。L和S片段在病毒粒子中并非等量,而是以2:1的摩尔比存在。每个片段上的基因分别被含有发卡结构非编码区隔开,5’端无帽状结构,3’端序列保守。由于S片段较L片段更为保守,因此常用S片段进行病毒进化研究和分类鉴定。Arenaviruses consist of an outer membrane and a nucleocapsid, are round in shape, contain a lipid (outer) membrane, and have a diameter of about 50-300nm (average 110-130nm). The surface of the outer membrane is covered with a protein-like filament with a length of about 10nm, and different numbers of ribosomes from the host cell can be seen inside, which looks like sand grains under the electron microscope, hence the name arenavirus. The viral genome is composed of bidirectional segmented single-stranded negative-sense RNA, the larger one is the L segment, about 7400 nucleotides in length, encoding the RNA-dependent RNA polymerase L protein and the Z protein with transcription and replication regulation functions; The smaller one is the S segment, about 3400 nucleotides in length, encoding nucleoprotein NP and glycoprotein GP. L and S fragments are not present in equal amounts in the virion but in a 2:1 molar ratio. The genes on each fragment are separated by a non-coding region containing a hairpin structure, there is no cap structure at the 5' end, and the sequence at the 3' end is conserved. Since the S segment is more conservative than the L segment, the S segment is often used for virus evolution research and classification identification.
根据ICTV(国际病毒学分类委员会)2018年最新颁布病毒分类(https://talk.ictvonline.org/taxonomy/),沙粒病毒科分为4个属:Antennavirus、Hartmanivirus、Mammarenavirus和Reptarenavirus,包含43个种。哺乳动物沙粒病毒属(Mammarenavirus)中35个种,可分为旧世界沙粒病毒和新世界沙粒病毒,旧世界沙粒病毒中,代表病毒是淋巴细胞脉络丛脑膜炎病毒简称LCMV病毒。新世界沙粒病毒主要包括有4个clade,clade A有Pirital,Pichinde,Flexal,Parana和Alloahuayo virus五种病毒;cladeB有Junin,Machupo,Guanarito,Amapari,Tacaribe,Sabia,Cupixi和Chapare viruses八种病毒;clade C有Oliveros和Latino两种病毒;clade A/Rec包括有Whitewater Arroyo,Tamiami和Bear Canyo三种病毒;系统进化树显示Lujo virus属于新世界沙粒病毒,但不在四个clade中。对人致病的沙粒病毒主要有拉沙病毒(Lassa virus)引起拉沙热,胡宁病毒(Junin virus)引起阿根廷出血热,马秋波病毒(Machupo virus)和查帕雷病毒(Chaparevirus)引起玻利维亚出血热,卢约病毒(Lujo virus)引起卢约出血热,瓜纳瑞托病毒(Guanarito virus)引起委内瑞拉出血热,萨比亚病毒(Sabid virus)引起巴西出血热,淋巴细胞脉络丛脑膜炎病毒(LCMV)引起淋巴细胞脉络丛脑膜炎。According to the latest virus classification issued by ICTV (International Committee on Virological Classification) in 2018 (https://talk.ictvonline.org/taxonomy/), Arenaviridae is divided into 4 genera: Antennavirus, Hartmanivirus, Mammarenavirus and Reptarenavirus, including 43 species. There are 35 species in the genus Mammarenavirus, which can be divided into Old World arenaviruses and New World arenaviruses. Among the Old World arenaviruses, the representative virus is lymphocytic choriomeningitis virus (LCMV). New world arenavirus mainly includes 4 clades, clade A has five viruses of Pirital, Pichinde, Flexal, Parana and Alloahuayo virus; clade B has eight viruses of Junin, Machupo, Guanarito, Amapari, Tacaribe, Sabia, Cupixi and Chapare viruses ; clade C has two viruses, Oliveros and Latino; clade A/Rec includes three viruses, Whitewater Arroyo, Tamiami and Bear Canyon; phylogenetic tree shows that Lujo virus belongs to the New World arenavirus, but it is not in the four clades. The arenaviruses that are pathogenic to humans mainly include Lassa virus causing Lassa fever, Junin virus causing Argentine hemorrhagic fever, Machupo virus and Chaparevirus causing Bolivian hemorrhagic fever, Lujo virus causes Lujo hemorrhagic fever, Guanarito virus causes Venezuelan hemorrhagic fever, Sabid virus causes Brazilian hemorrhagic fever, lymphocytic choriomeningitis Virus (LCMV) causes lymphocytic choriomeningitis.
塔卡里伯病毒(Tacaribe virus)于1956年在特立尼达的果蝠(Oryzomys gaeldi)中首次被发现,已有实验室工作者通过接触实验室气溶胶感染而致病,该病毒主要在特立尼达地区的蝙蝠中传播;太米阿米病毒(Tamiami virus)于1970年在美国佛罗里达州棉鼠(Sigmodon hispidus)中首次被发现,病毒主要局限在美国佛罗里达州地区的啮齿类动物中传播。Tacaribe virus (Tacaribe virus) was first discovered in Trinidad fruit bats (Oryzomys gaeldi) in 1956, and laboratory workers have been infected by contact with laboratory aerosols. The virus is mainly in Circulated in bats in the Trinidad area; Tamiami virus was first identified in Florida cotton rats (Sigmodon hispidus) in 1970, and the virus is mainly confined to rodents in the Florida area of the United States spread.
病毒病实验室检测主要依靠于病毒分离、血清学检测和病毒核酸检测。病毒核酸检测主要是基于PCR技术,实时荧光定量RT-PCR有着快速、高灵敏度和特异度的优点,是目前运用较多的实验室检测方法。该方法基于荧光共振能量迁移的原理,通过对荧光强度变化监测产物量的变化,随着反应时间的进行,将监测到的荧光信号的变化绘制一条曲线。该方法全程闭管操作,降低了污染的风险;对PCR产物除了可以进行定性分析,也可通过绘制标准曲线进行定量分析。Laboratory testing of viral diseases mainly relies on virus isolation, serological testing, and viral nucleic acid testing. Viral nucleic acid detection is mainly based on PCR technology. Real-time fluorescent quantitative RT-PCR has the advantages of rapidity, high sensitivity and specificity, and is currently the most widely used laboratory detection method. The method is based on the principle of fluorescence resonance energy transfer, monitors the change of the product amount through the change of the fluorescence intensity, and draws a curve for the change of the monitored fluorescence signal as the reaction time progresses. This method is operated in a closed tube throughout the process, which reduces the risk of contamination; in addition to qualitative analysis of PCR products, quantitative analysis can also be performed by drawing a standard curve.
发明内容Contents of the invention
本发明的目的在于提供一种灵敏、特异,可分别检测塔卡里伯病毒和太米阿米病毒的实时荧光定量RT-PCR引物探针组合、试剂盒及方法。The purpose of the present invention is to provide a sensitive and specific real-time fluorescence quantitative RT-PCR primer-probe combination, kit and method that can detect Takaribe virus and Taimiami virus respectively.
为实现上述目的,本发明的技术方案如下:在NCBI(https://www.ncbi.nlm.nih.gov/taxonomy)等数据库中检索下载塔卡里伯病毒和太米阿米病毒的基因组序列,选择具有较明确分离日期和地区的较完整病毒基因组序列、标明标准株的基因组序列的病毒基因组序列。评估病毒基因组序列的方向是否需要矫正,去除个别质量差的N碱基序列,查阅相关条目信息资料,确定序列纳入标准为有清楚的病毒分离年代、地区等资料。将序列文件进行整体和局部比对分析,确定各基因序列的分类。根据序列比对分析结果,同时结合病毒基因组序列中DNA聚合酶优先结合位点和最优变性温度的分析,筛选确定在各病毒基因型中高度保守的靶序列,根据靶序列分别设计特异性引物和探针,经大量筛选和人工优化获得序列分别如SEQ ID NO.1-4、SEQ ID NO.5-6所示的分别针对塔卡里伯病毒和太米阿米病毒的两对特异性引物和两条特异性探针,获得检测塔卡里伯病毒和太米阿米病毒检测的实时荧光定量RT-PCR的引物探针组合。To achieve the above object, the technical scheme of the present invention is as follows: search and download the genome sequences of Takaribe virus and Taimi virus in databases such as NCBI (https://www.ncbi.nlm.nih.gov/taxonomy) , select a more complete viral genome sequence with a clearer isolation date and region, and a viral genome sequence that indicates the genome sequence of the standard strain. Evaluate whether the direction of the viral genome sequence needs to be corrected, remove individual N-base sequences of poor quality, consult relevant entry information, and determine the sequence inclusion criteria as having clear virus isolation age, region and other information. The overall and partial comparison analysis is performed on the sequence files to determine the classification of each gene sequence. According to the results of sequence comparison analysis, combined with the analysis of the preferential binding site of DNA polymerase in the viral genome sequence and the optimal denaturation temperature, screen and determine the target sequence that is highly conserved in each virus genotype, and design specific primers according to the target sequence And probes, after a large number of screening and artificial optimization, the sequences are respectively shown in SEQ ID NO.1-4 and SEQ ID NO.5-6, and two pairs of specificities for Takaribe virus and Taimi virus respectively Primers and two specific probes are used to obtain a combination of primers and probes for real-time fluorescent quantitative RT-PCR for the detection of Takaribe virus and Taimi Ami virus.
具体而言,本发明的技术方案如下:Specifically, the technical scheme of the present invention is as follows:
本发明提供用于塔卡里伯病毒和太米阿米病毒的实时荧光定量RT-PCR检测的靶序列组合,其含有两条靶序列,所述靶序列具有如SEQ ID NO.7-8所示的核苷酸序列。The present invention provides a target sequence combination for the real-time fluorescence quantitative RT-PCR detection of Takaribe virus and Taimi virus, which contains two target sequences, and the target sequences have the following characteristics as shown in SEQ ID NO.7-8 The nucleotide sequence shown.
上述靶序列组合中,塔卡里伯病毒的靶序列如SEQ ID NO.7所示,太米阿米病毒的靶序列如SEQ ID NO.8所示。上述序列在各病毒的不同基因型中具有高度的保守性且易于进行PCR扩增,可适用于各病毒不同基因型的高效检测。Among the above target sequence combinations, the target sequence of Takaribe virus is shown in SEQ ID NO.7, and the target sequence of Taimiamivirus is shown in SEQ ID NO.8. The above sequences are highly conserved among different genotypes of each virus and are easy to perform PCR amplification, and are applicable to efficient detection of different genotypes of each virus.
本发明提供用于塔卡里伯病毒和太米阿米病毒的实时荧光定量RT-PCR检测的引物探针组合,其含有两对特异性引物和两条特异性探针,其中,所述特异性引物的序列如SEQ ID NO.1-4所示,所述特异性探针的序列如SEQ ID NO.5-6所示。The present invention provides a primer probe combination for real-time fluorescent quantitative RT-PCR detection of Takaribe virus and Taimi virus, which contains two pairs of specific primers and two specific probes, wherein the specific The sequence of the specific primer is shown in SEQ ID NO.1-4, and the sequence of the specific probe is shown in SEQ ID NO.5-6.
上述特异性引物和特异性探针中,针对塔卡里伯病毒的特异性引物的序列如SEQID NO.1-2所示,特异性探针序列如SEQ ID NO.5所示;针对太米阿米病毒的特异性引物的序列如SEQ ID NO.3-4所示,特异性探针序列如SEQ ID NO.6所示。Among the above-mentioned specific primers and specific probes, the sequence of specific primers for Takaribe virus is shown in SEQ ID NO.1-2, and the specific probe sequence is shown in SEQ ID NO.5; The sequence of the specific primer of Amida virus is shown in SEQ ID NO.3-4, and the specific probe sequence is shown in SEQ ID NO.6.
作为优选,所述特异性探针分别标记产生不同荧光色的荧光基团,所述荧光基团包括荧光报告基团和荧光猝灭基团,所述荧光报告基团为选自FAM、HEX、Texas Red、CY5、TET、JOE、CY3、TAMRA、ROX、LC RED640、LC RED705中的任一种;所述荧光猝灭基团为选自BHQ1、BHQ2、BHQ3、Dabcyl中的任一种。Preferably, the specific probes are respectively labeled with fluorescent groups that produce different fluorescent colors, and the fluorescent groups include a fluorescent reporter group and a fluorescent quencher group, and the fluorescent reporter group is selected from FAM, HEX, Any one in Texas Red, CY5, TET, JOE, CY3, TAMRA, ROX, LC RED640, LC RED705; Described fluorescence quenching group is any one selected from BHQ1, BHQ2, BHQ3, Dabcyl.
进一步优选地,序列如SEQ ID NO.5所示特异性探针的5’端标记FAM荧光报告基团,3’端标记B H Q 1荧光淬灭基团;序列如SEQ ID NO.6所示的特异性探针的5’端标记HEX荧光报告基团,3’端标记BHQ1荧光淬灭基团。Further preferably, the sequence is as shown in SEQ ID NO.5. The 5' end of the specific probe is marked with a FAM fluorescent reporter group, and the 3' end is marked with a BHQ1 fluorescence quencher group; the sequence is as shown in SEQ ID NO.6. The 5' end of the indicated specific probe is labeled with the HEX fluorescent reporter group, and the 3' end is labeled with the BHQ1 fluorescent quencher group.
作为优选,所述试剂盒还包含塔卡里伯病毒和太米阿米病毒的阳性对照标准品。Preferably, the kit also includes positive control standards for Takaribe virus and Taimiami virus.
所述塔卡里伯病毒的阳性对照优选为如SEQ ID NO.7所示的DNA序列对应的RNA或者塔卡里伯病毒RNA。所述太米阿米病毒的阳性对照优选为如SEQ ID NO.8所示的DNA序列对应的RNA或者太米阿米病毒RNA。The positive control of the Takaribe virus is preferably the RNA corresponding to the DNA sequence shown in SEQ ID NO.7 or the Takaribe virus RNA. The positive control of the tamiamivirus is preferably the RNA corresponding to the DNA sequence shown in SEQ ID NO.8 or the tamiamivirus RNA.
进一步优选地,所述试剂盒还包含其它为实现实时荧光定量RT-PCR检测的试剂,包括但不限于反应缓冲液、酶和水等。Further preferably, the kit also contains other reagents for real-time fluorescent quantitative RT-PCR detection, including but not limited to reaction buffer, enzyme and water.
本发明所述引物探针组合或所述试剂盒在进行分别实时荧光定量RT-PCR检测时的反应程序可根据所使用的逆转录酶和聚合酶的特性确定。The reaction program of the primer-probe combination or the kit in the present invention when performing real-time fluorescent quantitative RT-PCR detection can be determined according to the characteristics of the reverse transcriptase and polymerase used.
作为优选,所述引物探针组合或所述试剂盒在进行实时荧光定量RT-PCR检测时的反应程序为:50℃逆转录30min;95℃预变性10min,95℃变性15s、60℃退火60s运行40个循环。Preferably, the reaction program of the primer-probe combination or the kit when performing real-time fluorescent quantitative RT-PCR detection is: reverse transcription at 50°C for 30 minutes; pre-denaturation at 95°C for 10 minutes, denaturation at 95°C for 15 seconds, and annealing at 60°C for 60 seconds Run 40 cycles.
采用上述反应程序,能够更好地保证塔卡里伯病毒和太米阿米病毒的高效扩增检测。By adopting the above-mentioned reaction procedure, the high-efficiency amplification detection of Takaribe virus and Taimiami virus can be better ensured.
本发明所述引物探针组合或所述试剂盒在进行实时荧光定量RT-PCR检测时的反应体系中,上游引物、下游引物和探针的摩尔比为2:2:1。更优选地,在进行实时荧光定量RT-PCR检测时的25μL反应体系为:2×缓冲液12.5μL,10μM上游引物0.5μL,10μM下游引物0.5μL,10μM探针0.25μL,酶1μL,模板5μL,无RNA水解酶的去离子水补足至25μL。In the reaction system of the primer-probe combination or the kit of the present invention when performing real-time fluorescence quantitative RT-PCR detection, the molar ratio of the upstream primer, the downstream primer and the probe is 2:2:1. More preferably, the 25 μL reaction system when performing real-time fluorescent quantitative RT-PCR detection is: 12.5 μL of 2× buffer, 0.5 μL of 10 μM upstream primer, 0.5 μL of 10 μM downstream primer, 0.25 μL of 10 μM probe, 1 μL of enzyme, and 5 μL of template , make up to 25 μL with RNA hydrolase-free deionized water.
本发明提供的引物探针组合可在不同的反应体系中分别进行塔卡里伯病毒和太米阿米病毒的检测,以上所述的上游引物为SEQ ID NO.1、3所示引物中的任一条,下游引物为SEQ ID NO.2、4所示引物中的任一条,探针为SEQ ID NO.5、6所示的探针中的任一条。The combination of primers and probes provided by the present invention can be used to detect Takaribe virus and Taimiamivirus respectively in different reaction systems, and the above-mentioned upstream primers are those in the primers shown in SEQ ID NO. Any one, the downstream primer is any one of the primers shown in SEQ ID NO.2,4, and the probe is any one of the probes shown in SEQ ID NO.5,6.
本发明还提供所述的引物探针组合或所述的试剂盒在检测塔卡里伯病毒和太米阿米病毒中的应用。The present invention also provides the application of the primer-probe combination or the kit in the detection of Takaribe virus and Taimi virus.
比如,在一些实施方案中,可以通过检测人或动物的离体样本,来判断其是否感染塔卡里伯病毒和/或太米阿米病毒。在一些实施方案中,还可以检测食品(尤其是动物源性食品)或其他可能感染上述病毒的样本,以利于塔卡里伯病毒和太米阿米病毒的监测工作及流行病学研究。For example, in some embodiments, it is possible to determine whether a human or animal is infected with Takaribe virus and/or Tamiami virus by testing an isolated sample. In some embodiments, food (especially food of animal origin) or other samples that may be infected with the above-mentioned viruses can also be tested, so as to facilitate the monitoring work and epidemiological research of Takaribe virus and Tamiami virus.
本发明还提供一种利用实时荧光定量RT-PCR分别检测塔卡里伯病毒和太米阿米病毒方法,其为以待测样品的RNA为模板,利用如SEQ ID NO.1-4所示的特异性引物和如SEQID NO.5-6所示的特异性探针进行实时荧光定量RT-PCR检测,根据扩增曲线判断待测样品中是否含有塔卡里伯病毒和太米阿米病毒。The present invention also provides a method for using real-time fluorescent quantitative RT-PCR to detect Takaribe virus and Taimiami virus respectively, which uses the RNA of the sample to be tested as a template, and utilizes the method shown in SEQ ID NO.1-4 The specific primers and the specific probes shown in SEQID NO.5-6 are used for real-time fluorescent quantitative RT-PCR detection, and the amplification curve is used to determine whether the sample to be tested contains Takaribe virus and Taimiami virus .
上述提取病毒总RNA的方法可采用本领域常规方法,如离心柱提取法。The above-mentioned method for extracting total viral RNA can adopt conventional methods in the art, such as spin column extraction.
作为优选,所述实时荧光定量RT-PCR的反应程序为:50℃逆转录30min;95℃预变性10min,95℃变性15s、60℃退火60s运行40个循环。。Preferably, the reaction program of the real-time fluorescent quantitative RT-PCR is: reverse transcription at 50°C for 30 minutes; pre-denaturation at 95°C for 10 minutes, denaturation at 95°C for 15 seconds, and annealing at 60°C for 60 seconds for 40 cycles. .
作为优选,在进行实时荧光定量RT-PCR检测时的反应体系中,上游引物、下游引物和探针的摩尔比为2:2:1。更优选的,所述实时荧光定量RT-PCR的25μL反应体系为:2×缓冲液12.5μL,10μM上游引物0.5μL,10μM下游引物0.5μL,10μM探针0.25μL,酶1μL,模板5μL,无RNA水解酶的去离子水补足至25μL。Preferably, in the reaction system when performing real-time fluorescent quantitative RT-PCR detection, the molar ratio of the upstream primer, downstream primer and probe is 2:2:1. More preferably, the 25 μL reaction system of the real-time fluorescence quantitative RT-PCR is: 12.5 μL of 2× buffer, 0.5 μL of 10 μM upstream primer, 0.5 μL of 10 μM downstream primer, 0.25 μL of 10 μM probe, 1 μL of enzyme, 5 μL of template, no Make up to 25 μL of deionized water for RNA hydrolase.
作为优选,上述根据扩增曲线判断待测样品中是否含有塔卡里伯病毒和太米阿米病毒的方法如下:As preferably, the above-mentioned method for judging whether the sample to be tested contains Takaribe virus and Taimi Ami virus according to the amplification curve is as follows:
有效结果判定:阳性对照(或检测管内标)Ct≤35且有扩增曲线,阴性对照管无扩增曲线或CT值>38;Judgment of valid results: Positive control (or internal standard of detection tube) has Ct≤35 and has an amplification curve, negative control tube has no amplification curve or CT value>38;
若检测样品管中所测病原体对应荧光通道有扩增曲线且Ct<35,则可判断对应的该病原体检测阳性;若检测样品在检测通道无扩增曲线或Ct>38,可判样品为该病毒检测阴性;若检测样品在检测通道35<Ct<38,为可疑,建议复检,若复检结果Ct<38则可判样品为阳性,若复检结果无扩增曲线或Ct≥38,可判样品为阴性;If there is an amplification curve corresponding to the fluorescence channel of the pathogen measured in the detection sample tube and Ct<35, it can be judged that the corresponding pathogen is detected positive; if the detection sample has no amplification curve or Ct>38 in the detection channel, it can be judged that the sample is the The virus test is negative; if the test sample is suspicious in the detection channel 35<Ct<38, it is recommended to retest. If the retest result Ct<38, the sample can be judged as positive. If the retest result has no amplification curve or Ct≥38, The sample can be judged as negative;
无效结果的判定:若检测样品为阴性,则反应体系的阳性对照(或检测管内标)必须为阳性,否则该检验管结果无效,需进行复检。Judgment of invalid results: If the test sample is negative, the positive control of the reaction system (or the internal standard of the test tube) must be positive, otherwise the result of the test tube is invalid and a retest is required.
上述结果判定中,塔卡里伯病毒的阳性对照优选为如SEQ ID NO.7所示的DNA序列对应的RNA或者塔卡里伯病毒RNA。所述太米阿米病毒的阳性对照优选为如SEQ ID NO.8所示的DNA序列对应的RNA或者太米阿米病毒RNA。In the determination of the above results, the positive control of Takaribe virus is preferably RNA corresponding to the DNA sequence shown in SEQ ID NO.7 or Takaribe virus RNA. The positive control of the tamiamivirus is preferably the RNA corresponding to the DNA sequence shown in SEQ ID NO.8 or the tamiamivirus RNA.
本发明所述的塔卡里伯病毒和太米阿米病毒的实时荧光定量RT-PCR检测反应体系适用于所有的实时荧光定量PCR仪。The real-time fluorescent quantitative RT-PCR detection reaction system of Takaribe virus and Taimiami virus described in the present invention is applicable to all real-time fluorescent quantitative PCR instruments.
本发明的有益效果在于:The beneficial effects of the present invention are:
本发明结合相关病原体出现的几率、流行的风险和实验室检测过程的可操作性,形成以塔卡里伯病毒和太米阿米病毒为检测靶标的新的组合检测方案。The present invention combines the probability of occurrence of relevant pathogens, the risk of prevalence and the operability of the laboratory detection process to form a new combined detection scheme with Takaribe virus and Taimiami virus as detection targets.
本发明通过大量序列比对分析确定了塔卡里伯病毒和太米阿米病毒高度保守的靶序列,针对确定的靶序列通过大量筛选和优化,分别获得了适用于实时荧光定量RT-PCR检测的特异性引物和探针,该引物和探针在塔卡里伯病毒和太米阿米病毒的各个基因型中具有很好的普适性。The present invention has determined the highly conserved target sequences of Takaribe virus and Taimiamivirus through a large number of sequence comparison analysis, and obtained target sequences suitable for real-time fluorescent quantitative RT-PCR detection respectively through a large number of screening and optimization for the determined target sequences. The specific primers and probes have good universality in each genotype of Takaribe virus and Taimi virus.
本发明建立了检测塔卡里伯病毒和太米阿米病毒的单独或同时实时荧光定量RT-PCR检测方法。该方法在一个实时荧光定量RT-PCR反应体系内,引入分别或同时针对塔卡里伯病毒和太米阿米病毒的两对特异性引物和不同标记的探针,通过实时荧光信号的动态变化,对未知样本进行定性分析;也可通过标准参考品的检测,绘制标准曲线,实现对未知模板的定量分析。与其它检测方法相比,本发明提供的检测方法具有高灵敏性和特异性、操作简便、检测时间短、所需样本量少、低污染等优点,可直接对未知样本里提取的RNA进行检测,在病毒的快速检测中具有较高的应用价值。在人兽共患病发生率不断提高的形势下,本发明在疾病的早发现、早诊断方面具有重要意义。The invention establishes a separate or simultaneous real-time fluorescent quantitative RT-PCR detection method for detecting Takaribe virus and Taimiami virus. In this method, two pairs of specific primers and differently labeled probes are introduced into a real-time fluorescence quantitative RT-PCR reaction system respectively or simultaneously for Takaribe virus and Taimiami virus, and the dynamic changes of real-time fluorescent signals , perform qualitative analysis on unknown samples; it can also draw a standard curve through the detection of standard reference products to achieve quantitative analysis on unknown templates. Compared with other detection methods, the detection method provided by the present invention has the advantages of high sensitivity and specificity, simple operation, short detection time, less required sample volume, low pollution, etc., and can directly detect RNA extracted from unknown samples , which has high application value in the rapid detection of viruses. Under the situation that the incidence of zoonotic diseases is constantly increasing, the present invention has great significance in early detection and diagnosis of diseases.
附图说明Description of drawings
图1为本发明实施例4中实时荧光定量RT-PCR检测不同浓度的塔卡里伯病毒体外转录RNA模板的扩增曲线图。FIG. 1 is a graph showing the amplification curves of RNA templates transcribed in vitro by Takaribe virus at different concentrations detected by real-time fluorescent quantitative RT-PCR in Example 4 of the present invention.
图2为本发明实施例4中实时荧光定量RT-PCR检测不同浓度的太米阿米病毒体外转录RNA模板的扩增曲线图。Fig. 2 is a graph showing the amplification curves of RNA templates transcribed in vitro by real-time fluorescent quantitative RT-PCR detected with different concentrations of Tamiamivirus in Example 4 of the present invention.
具体实施方式Detailed ways
以下实施例用于说明本发明,但不用来限制本发明的范围。The following examples are used to illustrate the present invention, but are not intended to limit the scope of the present invention.
实施例中未注明具体技术或条件者,按照本领域内的文献所描述的技术或条件,或者按照产品说明书进行。所用试剂或仪器未注明生产厂商者,均为可通过正规渠道商购买得到的常规产品。If no specific technique or condition is indicated in the examples, it shall be carried out according to the technique or condition described in the literature in this field, or according to the product specification. The reagents or instruments used were not indicated by the manufacturer, and they were all conventional products that can be purchased through formal channels.
实施例1塔卡里伯病毒和太米阿米病毒的特异性引物和探针的设计The design of specific primers and probes of Takaribe virus and Taimi Ami virus of embodiment 1
1、引物和探针的设计和筛选1. Design and screening of primers and probes
在NCBI(https://www.ncbi.nlm.nih.gov/taxonomy)等公开数据库中检索下载塔卡里伯病毒和太米阿米病毒的基因组序列。选择具有较明确分离日期和地区的较完整病毒基因组序列、标明标准株的基因组序列的病毒基因组序列。评估病毒基因组序列的方向是否需要矫正,去除个别质量差的N碱基序列,查阅相关条目信息资料,确定序列纳入标准为有清楚的病毒分离年代、地区等资料。将序列文件进行整体和局部比对分析,确定各基因序列的分类,根据序列比对分析结果筛选确定在塔卡里伯病毒和太米阿米病毒的各个基因型中高度保守的靶序列。Search and download the genome sequences of Takaribe virus and Taimi virus in public databases such as NCBI (https://www.ncbi.nlm.nih.gov/taxonomy). Select a more complete viral genome sequence with a clearer isolation date and region, and a viral genome sequence that indicates the genome sequence of the standard strain. Evaluate whether the direction of the viral genome sequence needs to be corrected, remove individual N-base sequences of poor quality, consult relevant entry information, and determine the sequence inclusion criteria as having clear virus isolation age, region and other information. The overall and partial comparison analysis of the sequence files was carried out to determine the classification of each gene sequence, and the highly conserved target sequences in each genotype of Takaribe virus and Taimiami virus were screened and determined according to the results of sequence comparison analysis.
针对上述靶序列设计特异性引物和探针,同时结合病毒基因组序列中DNA聚合酶优先结合位点和最优变性温度的分析进行特异性引物和探针的设计和筛选。本发明经过大量设计、筛选和对比实验发现,并非单单满足普通引物设计原则或采用引物设计软件所设计出的引物就能够实现高效特异灵敏的实时荧光定量RT-PCR检测塔卡里伯病毒和太米阿米病毒。本发明针对引物、探针与靶序列的亲和力和错配率、引物之间的二级结构以及引物与靶序列之间的二级结构以及引物的GC含量、Tm值、长度和扩增片段长度等进行了大量人工优化设计和筛选,最终得到如下分别针对塔卡里伯病毒和太米阿米病毒的特异性引物对和特异性探针:Design specific primers and probes for the above target sequences, and simultaneously design and screen specific primers and probes in combination with the analysis of the DNA polymerase preferential binding sites in the viral genome sequence and the optimal denaturation temperature. After a lot of design, screening and comparison experiments, the present invention finds that it is not only the primers that meet the general primer design principles or the primers designed by the primer design software can realize efficient, specific and sensitive real-time fluorescent quantitative RT-PCR detection of Takaribe virus and miami virus. The present invention is aimed at the affinity and mismatch rate of primers, probes and target sequences, the secondary structure between primers and the secondary structure between primers and target sequences, and the GC content, Tm value, length and length of amplified fragments of primers conducted a lot of manual optimization design and screening, and finally obtained the following specific primer pairs and specific probes for Takaribe virus and Taimi virus respectively:
塔卡里伯病毒:Takaribe virus:
特异性引物:Specific primers:
Tacaribe-F:5’-AGGGTGAGCAGTGTCTTATC(SEQ ID NO.1)-3’Tacaribe-F: 5'-AGGGTGAGCAGTGTCTTATC (SEQ ID NO.1)-3'
Tacaribe-R:5’-TGCCTTGAGAGTCCTTCCTAC(SEQ ID NO.2)-3’Tacaribe-R: 5'-TGCCTTGAGAGTCCTTCCTAC (SEQ ID NO.2)-3'
特异性探针:Specific probes:
Tacaribe-P:5’-ATTCAACCTGAAGACTGGCCGACTGACTG(SEQ ID NO.5)-3’Tacaribe-P: 5'-ATTCAACCTGAAGACTGGCCGACTGACTG(SEQ ID NO.5)-3'
太米阿米病毒:Taimiamivirus:
特异性引物:Specific primers:
Tamiami-F:5’-ATAACCTCCAATATCCACACCC-3’(SEQ ID NO.3)Tamiami-F: 5'-ATAACTCTCCAATATCCACACCC-3' (SEQ ID NO.3)
Tamiami-R:5’-TGTCGTTTCCCACAGCATC-3’(SEQ ID NO.4)Tamiami-R: 5'-TGTCGTTTCCCACAGCATC-3' (SEQ ID NO.4)
特异性探针:Specific probes:
Tamiami-P:5’-TTGTGAGAGCCAGGAGGATTCTCAGTTTCTTC-3’(SEQ ID NO.6)。Tamiami-P: 5'-TTGTGAGAGCCAGGAGGATTCTCAGTTTCTTC-3' (SEQ ID NO. 6).
2、引物和探针的合成2. Synthesis of primers and probes
上述引物和探针均由上海生工生物工程有限公司合成。其中,序列如SEQ ID NO.5所示的特异性探针的5’端标记FAM荧光报告基团,3’端标记Black Hole Quencher 1荧光淬灭基团;序列如SEQ ID NO.6所示的特异性探针的5’端标记HEX荧光报告基团,3’端标记Black Hole Quencher 1荧光淬灭基团。The above primers and probes were synthesized by Shanghai Sangon Bioengineering Co., Ltd. Among them, the 5' end of the specific probe shown in SEQ ID NO.5 is labeled with a FAM fluorescent reporter group, and the 3' end is marked with a Black Hole Quencher 1 fluorescence quencher; the sequence is shown in SEQ ID NO.6 The 5' end of the specific probe is labeled with the HEX fluorescent reporter group, and the 3' end is labeled with the Black Hole Quencher 1 fluorescence quencher group.
实施例2实时荧光定量RT-PCR检测塔卡里伯病毒和太米阿米病毒的检测方法的建立Example 2 Establishment of a detection method for real-time fluorescent quantitative RT-PCR detection of Takaribe virus and Taimi virus
1、病毒核酸的提取收集待测病毒的细胞培养上清,采用QIAamp Viral RNA MiniKit提取病毒核酸。1. Extraction of viral nucleic acid The cell culture supernatant of the virus to be tested was collected, and the viral nucleic acid was extracted using the QIAamp Viral RNA MiniKit.
2、阳性标准品的制备2. Preparation of positive standard
对于两种病毒,通过合成两种病毒基因的保守区(如SEQ ID NO.7-8所示)作为阳性标准品,将合成的目的基因克隆至pET-28a(+)载体中,酶切位点为NdeⅠ和XhoⅠ,基因合成与质粒克隆由北京天一辉远生物公司完成。用thermo公司2×PCR Mix试剂对克隆质粒中含有的目的基因进行普通PCR扩增,扩增引物用通用引物T7(TAATACGACTCACTATAGGG,SEQ IDNO.9)和T7t(ACATCCACTTTGCCTTTCTC,SEQ ID NO.10)。体外转录为RNA,纯化回收定量而获得。采用Qian公司Gel Extraction Kit试剂盒回收纯化PCR产物,Nanodrop紫外可见分光光度计对回收的DNA模板定量。采用Promega公司Ribomaxtm large scale RNA productionsystem-sf6 and T7试剂盒进行目的基因的RNA体外转录,Qian公司RNeasy mini kit对RNA体外转录产物回收。琼脂糖凝胶电泳分析体外转录获得的RNA模板(SFTSV-NP)的纯度后,使用DEPC处理水进行稀释后,采用Nanodrop分光光度计进行3次测量,保证测量的值在100-300ng/μL之间,取测量的平均值计算各纯化后RNA产物的质量浓度后,采用下列公式,计算各自的拷贝数浓度:For the two viruses, by synthesizing the conserved region of the two virus genes (as shown in SEQ ID NO.7-8) as a positive standard, the synthetic target gene is cloned into the pET-28a (+) vector, and the restriction site The points are NdeI and XhoI, and gene synthesis and plasmid cloning were completed by Beijing Tianyi Huiyuan Biological Company. The target gene contained in the cloned plasmid was amplified by common PCR with 2×PCR Mix reagent from Thermo Company, and the amplification primers were general primers T7 (TAATACGACTCACTATAGGG, SEQ ID NO.9) and T7t (ACATCCACTTTGCCTTTCTC, SEQ ID NO.10). It is transcribed into RNA in vitro, purified, recovered and quantified. The Gel Extraction Kit kit from Qian Company was used to recover and purify the PCR products, and the recovered DNA template was quantified by a Nanodrop UV-Vis spectrophotometer. The Ribomaxtm large scale RNA productionsystem-sf6 and T7 kits from Promega Company were used for RNA in vitro transcription of target genes, and the RNeasy mini kit of Qian Company was used to recover RNA in vitro transcription products. After analyzing the purity of the RNA template (SFTSV-NP) obtained by in vitro transcription by agarose gel electrophoresis, after diluting with DEPC-treated water, use a Nanodrop spectrophotometer to perform three measurements to ensure that the measured value is between 100-300ng/μL After taking the measured average value to calculate the mass concentration of each purified RNA product, the following formula was used to calculate the respective copy number concentration:
Y(copies/μL)=[X(g/μL)/核苷酸的转录长度×340]×6.02×1023。Y (copies/μL)=[X (g/μL)/transcription length in nucleotides×340]×6.02×10 23 .
上述操作均按照试剂盒说明进行。The above operations were carried out according to the kit instructions.
3、实时荧光定量RT-PCR检测3. Real-time fluorescent quantitative RT-PCR detection
采用AgPath-ID One Step RT-PCR Kit(Ambion)试剂盒进行实时荧光定量RT-PCR反应,利用实施例1最终获得的特异性引物(序列如SEQ ID NO.1-4所示)和探针(序列如SEQID NO.5-6所示)进行实时荧光定量RT-PCR检测。Adopt AgPath-ID One Step RT-PCR Kit (Ambion) kit to carry out real-time fluorescent quantitative RT-PCR reaction, utilize the specific primer (sequence as shown in SEQ ID NO.1-4) and probe that embodiment 1 finally obtains (Sequence shown in SEQID NO.5-6) carry out real-time fluorescent quantitative RT-PCR detection.
本发明通过优化实施例1获得的用于两种病毒检测的特异性引物和探针的反应条件,使其能够实现高效的组合检测,具体反应条件如下:In the present invention, by optimizing the reaction conditions of the specific primers and probes for the detection of the two viruses obtained in Example 1, it can achieve efficient combined detection, and the specific reaction conditions are as follows:
25μL反应体系为:2×缓冲液12.5μL,10μM上游引物0.5μL,10μM下游引物0.5μL,10μM探针0.25μL,酶1μL,模板5μL,无RNA水解酶的去离子水补足至25μL;The 25 μL reaction system is: 12.5 μL of 2× buffer, 0.5 μL of 10 μM upstream primer, 0.5 μL of 10 μM downstream primer, 0.25 μL of 10 μM probe, 1 μL of enzyme, 5 μL of template, and deionized water without RNA hydrolase to make up to 25 μL;
反应程序为:50℃逆转录30min,95℃预变性10min,95℃变性15s、60℃退火60s运行40个循环。The reaction program was: reverse transcription at 50°C for 30 minutes, pre-denaturation at 95°C for 10 minutes, denaturation at 95°C for 15 seconds, and annealing at 60°C for 60 seconds for 40 cycles.
4、结果分析和判断4. Result analysis and judgment
检测结果需根据反应体系中所设置的阳性对照(或检测管内标)、用无RNA水解酶的去离子水作为阴性对照的扩增结果和扩增曲线进行判断。The test results need to be judged according to the positive control (or internal standard in the detection tube) set in the reaction system, the amplification result and the amplification curve using deionized water without RNA hydrolase as the negative control.
有效结果判定:阳性对照(或检测管内标)Ct≤35且有扩增曲线,阴性对照管无扩增曲线或CT值>38。Judgment of valid results: Positive control (or internal standard of detection tube) has Ct ≤ 35 and has an amplification curve, negative control tube has no amplification curve or CT value > 38.
若检测样品管中所测病原体对应荧光通道有扩增曲线且Ct<35,则可判断对应的该病原体检测阳性;若检测样品在检测通道无扩增曲线或Ct>38,可判样品为该病毒检测阴性;若检测样品在检测通道35<Ct<38,为可疑,建议复检,若复检结果Ct<38则可判样品为阳性,若复检结果无扩增曲线或Ct≥38,可判样品为阴性。If there is an amplification curve corresponding to the fluorescence channel of the pathogen measured in the detection sample tube and Ct<35, it can be judged that the corresponding pathogen is detected positive; if the detection sample has no amplification curve or Ct>38 in the detection channel, it can be judged that the sample is the The virus test is negative; if the test sample is suspicious in the detection channel 35<Ct<38, it is recommended to retest. If the retest result Ct<38, the sample can be judged as positive. If the retest result has no amplification curve or Ct≥38, The sample can be judged as negative.
无效结果的判定:若检测样品为阴性,则反应体系的阳性对照(或检测管内标)必须为阳性,否则该检验管结果无效,需进行复检。Judgment of invalid results: If the test sample is negative, the positive control of the reaction system (or the internal standard of the test tube) must be positive, otherwise the result of the test tube is invalid and a retest is required.
实施例3实时荧光定量RT-PCR检测方法的特异性分析The specificity analysis of embodiment 3 real-time fluorescent quantitative RT-PCR detection method
以塔卡里伯病毒和太米阿米病毒体外转录合成的RNA标准品作为阳性对照,将汉城病毒、汉滩病毒、发热伴血小板减少综合征布尼亚病毒、登革病毒1~4型病毒,鸠宁病毒、Sabia病毒、拉沙热病毒、马秋波病毒、瓜纳瑞托病毒、查帕雷病毒、卢约病毒和淋巴细胞脉络丛脑膜炎病毒共8种沙粒病毒RNA,和100份健康人血清RNA提取物作为对照病毒,对实施例2提供的检测方法进行特异性分析。With Takaribe virus and Taimiami virus in vitro transcribed and synthesized RNA standards as positive controls, Seoul virus, Hantaan virus, fever with thrombocytopenia syndrome bunya virus, and dengue virus type 1-4 were used as positive controls. , a total of 8 arenavirus RNAs of Junin virus, Sabia virus, Lassa fever virus, Maqiupo virus, Guanarito virus, Chapare virus, Ruyo virus and lymphocytic choriomeningitis virus, and 100 copies Serum RNA extracts from healthy people were used as a control virus, and specificity analysis was performed on the detection method provided in Example 2.
采用实施例2的检测方法进行实时荧光定量RT-PCR检测,具体处理组设计如下:以塔卡里伯病毒和太米阿米病毒体外转录合成的RNA标准品(浓度为1×108copies/uL)为阳性对照;以汉城病毒、汉滩病毒、发热伴血小板减少综合征布尼亚病毒、登革病毒1~4型病毒,鸠宁病毒、Sabia病毒、拉沙热病毒、马秋波病毒、瓜纳瑞托病毒、查帕雷病毒、卢约病毒和淋巴细胞脉络丛脑膜炎病毒共8种沙粒病毒RNA,和100份健康人血清RNA提取物进行特异性验证。The detection method of Example 2 was used for real-time fluorescent quantitative RT-PCR detection, and the design of the specific treatment group was as follows: RNA standard products (concentration: 1×10 8 copies/ μL) was used as positive control; Seoul virus, Hantaan virus, fever with thrombocytopenia syndrome bunya virus, dengue virus type 1-4 virus, Jiuning virus, Sabia virus, Lassa fever virus, horse Qiubo virus, Eight arenavirus RNAs including Guanarito virus, Chapare virus, Ruyo virus and lymphocytic choriomeningitis virus, and 100 healthy human serum RNA extracts were used for specificity verification.
结果如下表1所示。The results are shown in Table 1 below.
表1.三种沙粒病毒实时荧光定量RT-PCR检测方法特异性分析Table 1. Specificity analysis of three real-time fluorescent quantitative RT-PCR detection methods for arenaviruses
实施例4实时荧光定量RT-PCR检测方法的灵敏度(检测限)分析The sensitivity (detection limit) analysis of embodiment 4 real-time fluorescent quantitative RT-PCR detection method
对上述提取获得的塔卡里伯病毒和太米阿米病毒体外转录的RNA进行定量,根据如下公式计算RNA拷贝数:Y(copies/μl)=X(g/μl)×6.02×1023/Transcript length innucleotides×340,其中Y为RNA拷贝数,X为RNA的浓度。对上述已知浓度的RNA进行10倍系列稀释,对体外转录的塔卡里伯病毒和太米阿米病毒标准品RNA稀释成1×108copies/μL至1×101copies/μL共8个浓度梯度。Quantify the in vitro transcribed RNA of Takaribe virus and Taimiami virus extracted above, and calculate the RNA copy number according to the following formula: Y(copies/μl)=X(g/μl)×6.02×10 23 / Transcript length innucleotides×340, where Y is the RNA copy number and X is the concentration of RNA. Perform 10-fold serial dilutions of the above-mentioned known concentrations of RNA, and dilute the in vitro transcribed Takaribe virus and Taimiami virus standard RNA to 1×10 8 copies/μL to 1×10 1 copies/μL for a total of 8 a concentration gradient.
以上述梯度稀释的不同浓度的RNA为模板,采用实施例2中的检测方法进行实时荧光定量RT-PCR检测,,确定实施例2的检测方法的检测限。Using the above gradiently diluted RNA with different concentrations as a template, the detection method in Example 2 was used to perform real-time fluorescent quantitative RT-PCR detection, and the detection limit of the detection method in Example 2 was determined.
各病毒各浓度的扩增曲线如图1和图2所示,在图1-2中,由左至右的曲线分别依次为1×108copies/μL至1×101copies/μL8个浓度梯度的扩增结果。以不同浓度样本的拷贝数为横坐标,循环阈值(CT)为纵坐标,制作标准曲线,通过所得标准曲线获得两种病毒各自的单重实时荧光RT-PCR,结果如下表2所示,说明实施例2的检测方法具有良好的灵敏度。The amplification curves of each virus and each concentration are shown in Figure 1 and Figure 2. In Figure 1-2, the curves from left to right are 8 concentrations from 1×10 8 copies/μL to 1×10 1 copies/μL Amplification results of the gradient. Take the copy number of samples with different concentrations as the abscissa, and the cycle threshold (CT) as the ordinate to make a standard curve, and obtain the respective single-fold real-time fluorescent RT-PCR of the two viruses through the resulting standard curve. The results are shown in Table 2 below. The detection method of Example 2 has good sensitivity.
表2塔卡里伯病毒和太米阿米病毒的单重实时荧光定量RT-PCR结果Table 2 Single-plex real-time fluorescent quantitative RT-PCR results of Takaribe virus and Taimiami virus
实施例5实时荧光定量RT-PCR检测方法的可重复性分析The repeatability analysis of embodiment 5 real-time fluorescent quantitative RT-PCR detection method
分别选取稀释度为1×106copies/μL、1×104copies/μL、1×102copies/μL的三个不同浓度梯度的塔卡里伯病毒和太米阿米病毒体外转录RNA标准品为模板,分别进行5次平行重复实验验证实施例2提供的检测方法的稳定重复性。In vitro transcribed RNA standards for Takaribe virus and Tamiamivirus were selected at three different concentration gradients with dilutions of 1×10 6 copies/μL, 1×10 4 copies/μL, and 1×10 2 copies/μL The product was used as a template, and 5 parallel repeated experiments were carried out to verify the stable repeatability of the detection method provided in Example 2.
如表3所示,塔卡里伯病毒和太米阿米病毒各次检测实验的标准差均控制在0.5以内,变异系数1%以下,说明实施例2的检测方法具有较好的稳定性和可重复性。As shown in Table 3, the standard deviations of each detection experiment of Takaribe virus and Taimiami virus were all controlled within 0.5, and the coefficient of variation was below 1%, indicating that the detection method of Example 2 has good stability and repeatability.
表3塔卡里伯病毒和太米阿米病毒实时荧光定量RT-PCR检测方法的稳定性评价Table 3 Stability evaluation of real-time fluorescent quantitative RT-PCR detection methods for Takaribe virus and Taimiami virus
上文中用一般性说明及具体实施方案对本发明作了详尽的描述,但在本发明基础上,可以对之作一些修改或改进,这对本领域技术人员而言是显而易见的。因此,在不偏离本发明精神的基础上所做的这些修改或改进,均属于本发明要求保护的范围。The present invention has been described in detail with general descriptions and specific embodiments above, but it is obvious to those skilled in the art that some modifications or improvements can be made on the basis of the present invention. Therefore, the modifications or improvements made on the basis of not departing from the spirit of the present invention all belong to the protection scope of the present invention.
序列表sequence listing
<110> 中国疾病预防控制中心病毒病预防控制所<110> Institute of Viral Disease Prevention and Control, Chinese Center for Disease Control and Prevention
<120> 用于检测塔卡里伯病毒和太米阿米病毒的引物探针组合、试剂盒及方法<120> Primer-probe combination, kit and method for detecting Takaribe virus and Taimi virus
<130> KHP211110058.9<130> KHP211110058.9
<160> 10<160> 10
<170> SIPOSequenceListing 1.0<170> SIPOSequenceListing 1.0
<210> 1<210> 1
<211> 20<211> 20
<212> DNA<212> DNA
<213> 人工序列(Artificial Sequence)<213> Artificial Sequence (Artificial Sequence)
<400> 1<400> 1
agggtgagca gtgtcttatc 20agggtgagca gtgtcttatc 20
<210> 2<210> 2
<211> 21<211> 21
<212> DNA<212> DNA
<213> 人工序列(Artificial Sequence)<213> Artificial Sequence (Artificial Sequence)
<400> 2<400> 2
tgccttgaga gtccttccta c 21tgccttgaga gtccttccta c 21
<210> 3<210> 3
<211> 22<211> 22
<212> DNA<212> DNA
<213> 人工序列(Artificial Sequence)<213> Artificial Sequence (Artificial Sequence)
<400> 3<400> 3
ataacctcca atatccacac cc 22ataacctcca atatccaacac cc 22
<210> 4<210> 4
<211> 19<211> 19
<212> DNA<212>DNA
<213> 人工序列(Artificial Sequence)<213> Artificial Sequence (Artificial Sequence)
<400> 4<400> 4
tgtcgtttcc cacagcatc 19tgtcgtttcc cacagcatc 19
<210> 5<210> 5
<211> 29<211> 29
<212> DNA<212> DNA
<213> 人工序列(Artificial Sequence)<213> Artificial Sequence (Artificial Sequence)
<400> 5<400> 5
attcaacctg aagactggcc gactgactg 29attcaacctg aagactggcc gactgactg 29
<210> 6<210> 6
<211> 32<211> 32
<212> DNA<212>DNA
<213> 人工序列(Artificial Sequence)<213> Artificial Sequence (Artificial Sequence)
<400> 6<400> 6
ttgtgagagc caggaggatt ctcagtttct tc 32ttgtgagagc caggaggatt ctcagtttct tc 32
<210> 7<210> 7
<211> 200<211> 200
<212> DNA<212>DNA
<213> 人工序列(Artificial Sequence)<213> Artificial Sequence (Artificial Sequence)
<400> 7<400> 7
atttacagag gacgtgaaga accctgtttt gagggtgagc agtgtcttat caaaattcaa 60atttacagag gacgtgaaga accctgtttt gagggtgagc agtgtcttat caaaattcaa 60
cctgaagact ggccgactga ctgtaaggct gaccacacaa acacattccg ctttttatca 120cctgaagact ggccgactga ctgtaaggct gaccacacaa aacacattccg ctttttatca 120
aggagccaaa aaagcatagc tgtaggaagg actctcaagg catttttctc ctggtcgctt 180aggagccaaa aaagcatagc tgtaggaagg actctcaagg catttttctc ctggtcgctt 180
actgaccctt tagggaacga 200
<210> 8<210> 8
<211> 200<211> 200
<212> DNA<212> DNA
<213> 人工序列(Artificial Sequence)<213> Artificial Sequence (Artificial Sequence)
<400> 8<400> 8
ttacatggag tcagcagtgt cacgagaatc acatgagtgc catgcagctt ataacctcca 60ttacatggag tcagcagtgt cacgagaatc acatgagtgc catgcagctt ataacctcca 60
atatccacac ccaggttgtg agagccagga ggattctcag tttcttcacc tggtcgttgt 120atatccacac ccaggttgtg agagccagga ggattctcag tttcttcacc tggtcgttgt 120
cagatgctgt gggaaacgac atgccaggag ggtattgttt agaaaaatgg atgctgattg 180cagatgctgt gggaaacgac atgccaggag ggtattgttt agaaaaatgg atgctgattg 180
ccagccaact aaaatgtttt 200
<210> 9<210> 9
<211> 20<211> 20
<212> DNA<212> DNA
<213> 人工序列(Artificial Sequence)<213> Artificial Sequence (Artificial Sequence)
<400> 9<400> 9
taatacgact cactataggg 20
<210> 10<210> 10
<211> 20<211> 20
<212> DNA<212>DNA
<213> 人工序列(Artificial Sequence)<213> Artificial Sequence (Artificial Sequence)
<400> 10<400> 10
acatccactt tgcctttctc 20acatccactt tgcctttctc 20
Claims (12)
Priority Applications (1)
| Application Number | Priority Date | Filing Date | Title |
|---|---|---|---|
| CN202110096360.6A CN112662815B (en) | 2021-01-25 | 2021-01-25 | Primer-probe combination, kit and method for detecting Takara virus and Tamiami virus |
Applications Claiming Priority (1)
| Application Number | Priority Date | Filing Date | Title |
|---|---|---|---|
| CN202110096360.6A CN112662815B (en) | 2021-01-25 | 2021-01-25 | Primer-probe combination, kit and method for detecting Takara virus and Tamiami virus |
Publications (2)
| Publication Number | Publication Date |
|---|---|
| CN112662815A CN112662815A (en) | 2021-04-16 |
| CN112662815B true CN112662815B (en) | 2023-04-11 |
Family
ID=75414364
Family Applications (1)
| Application Number | Title | Priority Date | Filing Date |
|---|---|---|---|
| CN202110096360.6A Expired - Fee Related CN112662815B (en) | 2021-01-25 | 2021-01-25 | Primer-probe combination, kit and method for detecting Takara virus and Tamiami virus |
Country Status (1)
| Country | Link |
|---|---|
| CN (1) | CN112662815B (en) |
Family Cites Families (4)
| Publication number | Priority date | Publication date | Assignee | Title |
|---|---|---|---|---|
| CN103224999B (en) * | 2013-04-25 | 2015-11-18 | 中华人民共和国大榭出入境检验检疫局 | Detect degenerated primer and the RT-PCR detection method of arenavirus coe virus |
| TW201706415A (en) * | 2015-05-07 | 2017-02-16 | 新興病毒診斷有限公司 | Improved compositions and methods for detection of viruses |
| JP7239568B2 (en) * | 2017-11-09 | 2023-03-14 | ビスビュー メディカル,インコーポレイテッド | Portable molecular diagnostic device and method for detecting target virus |
| CN110305985B (en) * | 2019-06-21 | 2022-05-17 | 中国疾病预防控制中心病毒病预防控制所 | A method for detection of Zika virus, Chikungunya virus and Mayaro virus using triple real-time quantitative RT-PCR |
-
2021
- 2021-01-25 CN CN202110096360.6A patent/CN112662815B/en not_active Expired - Fee Related
Also Published As
| Publication number | Publication date |
|---|---|
| CN112662815A (en) | 2021-04-16 |
Similar Documents
| Publication | Publication Date | Title |
|---|---|---|
| CN110982943B (en) | A novel coronavirus RT-PCR detection method and kit | |
| CN113755565B (en) | Quadruple quantitative fluorescent probe primer combination, kit and identification method for identifying wild strain and vaccine strain of African swine fever | |
| CN107630109A (en) | A kind of fluorescence quantification PCR primer and kit for detecting Novel pig acute diarrhea syndrome coronavirus | |
| CN112080584A (en) | Primer, probe, kit and method for detecting largemouth black bass virus | |
| CN109825650A (en) | A kind of while four kinds of duck susceptible virus of detection multiple fluorescence quantitative PCR detection primers and probe combinations and detection method | |
| CN113789413A (en) | Primer pair, probe, kit and method for simultaneously detecting five lily viruses | |
| CN104017901A (en) | Method and kit for simultaneously detecting human type A and type B respiratory syncytial viruses and human metapneumoviruses | |
| CN112662809A (en) | Nucleic acid composition for detecting novel coronavirus COVID-19 and application thereof | |
| CN112662816B (en) | Primer-probe combination, kit and method for detection of Amapari virus, Copiceus virus and Epimeris virus | |
| CN112941240B (en) | Primer pair, kit and method for detecting goose astrovirus and goose chimeric calicivirus | |
| CN112708701B (en) | Primer probe combination, kit and method for detecting Orlihuas virus, pakana virus and Pickindred virus | |
| CN112662815B (en) | Primer-probe combination, kit and method for detecting Takara virus and Tamiami virus | |
| CN105838826B (en) | Double-color fluorescent PCR primer, probe and method for rapidly distinguishing canine parvovirus vaccine strain and wild strain | |
| CN111826473A (en) | A primer pair for detection of goose type 2 astrovirus by fluorescence quantitative PCR and its application | |
| CN112725534B (en) | Primer probe, target combination, kit and method for detecting karya virus, hazara virus and epstein-barr virus | |
| CN118166165A (en) | TaqMan Real-time Fluorescence Quantitative PCR Detection Kit for Feline Calicivirus and Its Application | |
| CN107400735A (en) | Detect the real-time fluorescent quantitative RT-PCR method of zika virus | |
| CN112662817B (en) | Primer probes, target combinations, kits and methods for the detection of Latino, Mobara, and Mopeia viruses | |
| CN110643740A (en) | Real-time fluorescence quantitative RT-PCR detection primers, probes and detection kits for Paliam serogroup virus | |
| CN113481324B (en) | Method and kit for detecting novel coronavirus and D614G mutant thereof | |
| CN116479177A (en) | A combination of primers and probes for the detection of six mutation sites in the S gene of novel coronavirus | |
| CN108823333A (en) | A kind of goose source kidney type astrovirus GoAstV quick diagnosis primed probe group, detection method and application | |
| CN104561386A (en) | Real-time fluorescent quantitative PCR detection method for apple stem grooving virus | |
| CN108130383A (en) | A kind of fluorescence quantitative detection kit for fowl metapneumovirus Classification Identification | |
| CN112746132B (en) | Primer probe combination, kit and method for detecting hope mountain virus, Mueller Shu virus and Riyogsongduo virus |
Legal Events
| Date | Code | Title | Description |
|---|---|---|---|
| PB01 | Publication | ||
| PB01 | Publication | ||
| SE01 | Entry into force of request for substantive examination | ||
| SE01 | Entry into force of request for substantive examination | ||
| GR01 | Patent grant | ||
| GR01 | Patent grant | ||
| CF01 | Termination of patent right due to non-payment of annual fee | ||
| CF01 | Termination of patent right due to non-payment of annual fee |
Granted publication date: 20230411 |



